Ashland Inc. provides additives and specialty ingredients worldwide. It operates through Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; and nutraceutical solutions comprising products for weight management, joint comfort, stomach and …
Over the last 12 months, insiders at Ashland Inc. have bought $0 and sold $675,366 worth of Ashland Inc. stock.
On average, over the past 5 years, insiders at Ashland Inc. have bought $28.42M and sold $59.46M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 224,156 shares for transaction amount of $22.46M was made by Sandler Ricky C (See Remarks) on 2022‑09‑01.
2024-12-05 | Sale | VP, Finance & Prinpl Acctg Off | 451 0.001% | $78.07 | $35,210 | -2.18% | ||
2024-11-19 | Sale | SVP, Gen Counsel and Secrty. | 162 0.0003% | $75.54 | $12,237 | 0.00% | ||
2024-11-15 | Sale | SVP, Gen Counsel and Secrty. | 868 0.0018% | $77.90 | $67,617 | -0.77% | ||
2024-09-04 | Sale | SVP and CFO | 5,487 0.0112% | $87.88 | $482,198 | -3.89% | ||
2024-02-16 | Sale | SVP, Gen Counsel and Secrty. | 844 0.0017% | $92.54 | $78,104 | +1.90% | ||
2023-12-07 | Sale | Principal Accounting Officer | 843 0.0016% | $82.38 | $69,446 | +9.04% | ||
2023-09-05 | Sale | Sr.VP &Chief Financial Officer | 7,866 0.0155% | $86.54 | $680,724 | +4.28% | ||
2022-09-01 | Sale | See Remarks | 224,156 0.415% | $100.20 | $22.46M | -0.44% | ||
2022-09-01 | Sale | 224,156 0.415% | $100.20 | $22.46M | -0.44% | |||
2022-09-01 | See Remarks | 224,156 0.415% | $100.20 | $22.46M | -0.44% | |||
2022-09-01 | 224,156 0.415% | $100.20 | $22.46M | -0.44% | ||||
2022-06-08 | Sale | Principal Accounting Officer | 2,657 0.0049% | $109.50 | $290,942 | -5.29% | ||
2022-06-07 | Sale | Principal Accounting Officer | 2,657 0.0049% | $109.50 | $290,942 | -6.83% | ||
2022-06-02 | Sale | Sr.VP &Chief Financial Officer | 4,235 0.0077% | $105.58 | $447,131 | -4.36% | ||
2022-06-01 | Sale | Sr.VP &Chief Financial Officer | 2,374 0.0044% | $105.58 | $250,647 | -2.08% | ||
2022-05-17 | See Remarks | 48,800 0.0901% | $101.27 | $4.94M | +2.28% | |||
2022-05-17 | 48,800 0.0901% | $101.27 | $4.94M | +2.28% | ||||
2021-09-10 | Sale | Chief Financial Officer | 2,208 0.0039% | $94.30 | $208,214 | +8.89% | ||
2021-06-03 | Sale | Principal Accounting Officer | 4,858 0.008% | $93.88 | $456,069 | +2.19% | ||
2020-12-28 | Sale | Chief Financial Officer | 8,148 0.0137% | $80.00 | $651,840 | +13.50% |
EMINENCE CAPITAL, LP | 4083978 8.6561% | $71.85 | 2 | 1 | +0.92% | |
Sandler Ricky C | See Remarks | 4083978 8.6561% | $71.85 | 2 | 2 | +0.92% |
NOVO GUILLERMO | Chairman and CEO | 12900 0.0273% | $71.85 | 1 | 0 | <0.0001% |
KALYANA SWAMINATHAN ASHOK | Sr VP & Gen Mgr, Life Sciences | 100 0.0002% | $71.85 | 1 | 0 | +14.77% |
The Vanguard Group | $470.78M | 9.65 | 4.83M | -2.71% | -$13.14M | 0.01 | |
BlackRock | $440.77M | 9.03 | 4.53M | +1.99% | +$8.62M | 0.01 | |
Eminence Capital LP | $319.9M | 6.55 | 3.29M | -6.56% | -$22.44M | 5.87 | |
Dimensional Fund Advisors | $261.55M | 5.36 | 2.69M | +1.05% | +$2.72M | 0.07 | |
Massachusetts Financial Services Co Ma | $205.98M | 4.22 | 2.12M | -12.76% | -$30.12M | 0.06 |